Tagrisso 40mg Tablet
Marketer
AstraZeneca
Salt Composition
Osimertinib (40mg)
Overview Tagrisso 40mg Tablet
Ozanimod 40mg tablets function as a kinase inhibitor, indicated for treating non-small cell lung carcinoma in adults exhibiting specific epidermal growth factor receptor (EGFR) mutations. Administration is flexible—with or without food—but consistent daily timing optimizes efficacy. Dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's prescribed regimen; improper use or overdose can lead to severe adverse events. Therapeutic effects may take weeks or months to manifest; discontinuation requires medical consultation. Diarrhea, a frequent side effect, necessitates increased fluid intake; persistent diarrhea requires medical attention. Report immediately any respiratory distress coupled with fever and cough, or intense skin exfoliation. This medication can lower white blood cell counts, raising infection risk, necessitating regular blood monitoring. Inform your healthcare provider about all concurrent medications due to potential interactions. Pregnancy and breastfeeding contraindicate its use; reliable contraception for both partners is crucial during treatment.
Uses of Tagrisso 40mg Tablet
Lung cancer (non-small cell type)
Major Benefits of Tagrisso 40mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tagrisso 40mg tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Tagrisso 40mg Tablet:
- Diarrhea
- Loss of appetite
- Rash
- Stomatitis (Inflammation of the mouth)
How to use Tagrisso 40mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 40mg Tagrisso tablet can be administered with or without food, although consistent timing is recommended.
How Tagrisso 40mg Tablet works:
Efabutinib 40mg tablets are a cancer treatment that inhibits the activity of a mutated protein responsible for cancer cell proliferation, thereby hindering or slowing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tagrisso 40mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of the medication Tagrisso 40mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Tagrisso 40mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates a potential for the medication to transfer into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Tagrisso 40mg tablets.
KidneySAFE IF PRESCRIBED
Individuals with kidney impairment can safely use Tagrisso 40mg tablets without requiring a change in dosage.
LiverSAFE IF PRESCRIBED
Ozanimod 40mg tablets are considered safe for administration to individuals with hepatic impairment. No modification of the Ozanimod 40mg tablet dosage is advised.
What if you forget to take Tagrisso 40mg Tablet :
Omit any missed Tagrisso 40mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Tagrisso 40mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Alkylated indoles |
| Potential for Dependence | None. |
| Medication Classification | Cancer-fighting drugs |
| Mechanism of Action | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently